dasatinib accord
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - Æxlishemjandi lyf - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - Æxlishemjandi lyf - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
cardosin retard forðatafla 4 mg
teva b.v.* - doxazosin mesilate - forðatafla - 4 mg
carduran retard forðatafla 4 mg
upjohn eesv - doxazosinum mesýlat - forðatafla - 4 mg
decutan mjúkt hylki 10 mg
teva b.v.* - isotretinoinum inn - mjúkt hylki - 10 mg
decutan mjúkt hylki 20 mg
teva b.v.* - isotretinoinum inn - mjúkt hylki - 20 mg
dropizol (dropium) dropar til inntöku, lausn 10 mg/ml
pharmanovia a/s - opium - dropar til inntöku, lausn - 10 mg/ml
duspatalin retard hart forðahylki 200 mg
viatris aps - mebeverinum hýdróklóríð - hart forðahylki - 200 mg
elvanse adult hart hylki 30 mg
takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 30 mg
elvanse adult hart hylki 50 mg
takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 50 mg